1
2
Code No. | Product | Discontinued date | Manufacturer |
---|---|---|---|
SPM553 | Peptide H-2Kd NRP-V7 KYNKANVFL | 2024/11/13 | MBLI |
SPC043 | ORF1ab polyprotein SARS-CoV-2 (5573-5580) Peptide | 2024/11/13 | MBLI |
SPC044 | Chain A, SARS-CoV-2 spike glycoprotein (263-270) Peptide | 2024/11/13 | MBLI |
SPC046 | SARS-CoV-2 chain A spike glycoprotein (363-377) Peptide | 2024/11/13 | MBLI |
SPC045 | Chain A, SARS-CoV-2 spike glycoprotein (449-456) Peptide | 2024/11/13 | MBLI |
SPC047 | SARS-CoV-2 surface glycoprotein (1216-1230) Peptide | 2024/11/13 | MBLI |
SPC048 | SARS-CoV-2 envelope protein (21-35) Peptide | 2024/11/13 | MBLI |
SPC049 | SARS-CoV-2 ORF7a protein (1-15) Peptide | 2024/11/13 | MBLI |
SPC050 | SARS-CoV-2 membrane glycoprotein (41-55) Peptide | 2024/11/13 | MBLI |
SPC051 | SARS-CoV-2 chain A spike glycoprotein (509-523) Peptide | 2024/11/13 | MBLI |
SPC052 | SARS-CoV-2 chain A spike glycoprotein (51-65) Peptide | 2024/11/13 | MBLI |
SPC003 | SARS-CoV-2 ORF1ab polyprotein (1801-1815) Peptide | 2024/11/13 | MBLI |
SPC004 | SARS-CoV-2 envelope protein (56-70) Peptide | 2024/11/13 | MBLI |
SPC005 | SARS-CoV-2 ORF1ab polyprotein (2211-2225) Peptide | 2024/11/13 | MBLI |
SPC009 | SARS-CoV-2 membrane glycoprotein (91-105) Peptide | 2024/11/13 | MBLI |
SPC010 | SARS-CoV-2 ORF1ab polyprotein (5016-5030) Peptide | 2024/11/13 | MBLI |
SPC011 | SARS-CoV-2 ORF1ab polyprotein (3946-3960) Peptide | 2024/11/13 | MBLI |
SPC012 | SARS-CoV-2 chain A spike glycoprotein (236-250) Peptide | 2024/11/13 | MBLI |
SPC014 | SARS-CoV-2 ORF3a protein (206-220) Peptide | 2024/11/13 | MBLI |
SPC016 | SARS-CoV-2 ORF1ab (3183-3191) Peptide | 2024/11/13 | MBLI |
SPC027 | SARS-CoV-2 ORF1ab (2600-2608) Peptide | 2024/11/13 | MBLI |
SPC029 | SARS-CoV-2 ORF1ab (6159-6167) Peptide | 2024/11/13 | MBLI |
SPC032 | Chain A, SARS-CoV-2 spike glycoprotein (539-546) Peptide | 2024/11/13 | MBLI |
SPC033 | Chain A, SARS-CoV-2 spike glycoprotein (902-909) Peptide | 2024/11/13 | MBLI |
SPC040 | Chain A, SARS-CoV-2 spike glycoprotein (424-433) Peptide | 2024/11/13 | MBLI |
SPC042 | ORF1ab polyprotein SARS-CoV-2 (5583-5591) Peptide | 2024/11/13 | MBLI |
SPC038 | Chain A, SARS-CoV-2 spike glycoprotein (1060-1068) Peptide | 2024/11/13 | MBLI |
SPC025 | SARS-CoV-2 ORF1ab (4892-4900) Peptide | 2024/11/13 | MBLI |
SPC039 | Chain A, SARS-CoV-2 spike glycoprotein (691-699) Peptide | 2024/11/13 | MBLI |
SPC031 | SARS-CoV-2 ORF1ab (3159-3167) Peptide | 2024/11/13 | MBLI |
SPC021 | SARS-CoV-2 ORF1ab (6419-6427) Peptide | 2024/11/13 | MBLI |
SPC002 | SARS-CoV-2 ORF1ab polyprotein (471-485) peptide | 2024/11/13 | MBLI |
SPC024 | SARS-CoV-2 ORF1ab (2192-2200) Peptide | 2024/11/13 | MBLI |
SPC034 | Chain A, SARS-CoV-2 spike glycoprotein (233-241) Peptide | 2024/11/13 | MBLI |
SPC022 | SARS-CoV-2 ORF1ab (6851-6859) Peptide | 2024/11/13 | MBLI |
SPC035 | Chain A, SARS-CoV-2 spike glycoprotein (511-518) Peptide | 2024/11/13 | MBLI |
SPC017 | SARS-CoV-2 ORF1ab (6749-6758) Peptide | 2024/11/13 | MBLI |
SPC037 | Chain A, SARS-CoV-2 spike glycoprotein (447-455) Peptide | 2024/11/13 | MBLI |
SPC008 | SARS-CoV-2 ORF3a protein (1-15) Peptide | 2024/11/13 | MBLI |
SPC023 | SARS-CoV-2 ORF3a protein (107-115) Peptide | 2024/11/13 | MBLI |
SPC041 | ORF1ab polyprotein SARS-CoV-2 (5385-5393) Peptide | 2024/11/13 | MBLI |
SPC020 | SARS-CoV-2 ORF1ab (3710-3718) Peptide | 2024/11/13 | MBLI |
SPC015 | SARS-CoV-2 ORF1ab (3122-3130) Peptide | 2024/11/13 | MBLI |
SPC036 | Chain A, SARS-CoV-2 spike glycoprotein (325-332) Peptide | 2024/11/13 | MBLI |
SPC001 | SARS-CoV-2 ORF1ab polyprotein (3906-3920) peptide | 2024/11/13 | MBLI |
SPC018 | SARS-CoV-2 ORF3a protein (139-147) Peptide | 2024/11/13 | MBLI |
SPC013 | SARS-CoV-2 nucleocapsid phosphoprotein (301-315) Peptide | 2024/11/13 | MBLI |
SPC028 | SARS-CoV-2 ORF1ab (1875-1883) Peptide | 2024/11/13 | MBLI |
SPC019 | SARS-CoV-2 ORF1ab (3732-3740) Peptide | 2024/11/13 | MBLI |
SPC030 | SARS-CoV-2 ORF1ab (4986-4994) Peptide | 2024/11/13 | MBLI |
SPC006 | SARS-CoV-2 nucleocapsid phosphoprotein (221-235) Peptide | 2024/11/13 | MBLI |
SPC026 | SARS-CoV-2 nucleocapsid phosphoprotein (362-370) Peptide | 2024/11/13 | MBLI |
SPC007 | SARS-CoV-2 membrane glycoprotein (176-190) Peptide | 2024/11/13 | MBLI |
TS-M812-P | DRB1*11:01 TT p2829-844 Peptide MQYIKANSKFIGITEL | 2023/11/02 | MBL |
TS-M048-P | HLA-A*02:01 HPV16 E7 peptide | 2023/11/02 | MBL |
TS-0029-P | HLA-A*02:01 Negative peptide | 2023/11/02 | MBL |
TS-M012-P | HLA-A*11:01 CMV pp65 peptide | 2023/11/02 | MBL |
TS-M136-P | HLA-A*24:02 PBF A24.2 peptide | 2023/11/02 | MBL |
TS-M507-P | H-2Kb MuLV p15E peptide | 2023/11/02 | MBL |
TS-M704-P | I-Ab MOG35-55 Peptide | 2023/11/02 | MBL |
TS-M727-P | I-Ag7 BDC2.5 mimotope Peptide | 2022/04/28 | MBL |
TS-M811-P | DRB1*04:01 GAD65555-567 Peptide NFFRMVISNPAAT | 2022/04/28 | MBL |
TS-M722-P | I-Ab mouse 2W1S Peptide | 2022/04/28 | MBL |
TS-M716-P | I-Ab Influenza NP311-325 Peptide | 2022/04/28 | MBL |
TS-M153-P | HLA-A*24:02 Control Peptide | 2022/04/28 | MBL |
TS-M534-P | H-2Kd Influenza NP Peptide | 2022/04/28 | MBL |
TS-M088-P | HLA-A*02:01 MUC1 peptide | 2022/04/28 | MBL |
TS-M815-P | HLA-DRB1*01:01 HTLV-1 Tax155-167 Peptide YLYQLSPPITWPL | 2022/04/28 | MBL |
TS-0010-P | HLA-A*02:01 CMV pp65 peptide | 2022/04/28 | MBL |
TS-0018-P | HLA-A*02:01 HBV core peptide | 2022/04/28 | MBL |
TS-0020-P | HLA-A*24:02 CMV pp65 peptide | 2022/04/28 | MBL |
TS-0022-P | HLA-A*24:02 HBV core peptide | 2022/04/28 | MBL |
TS-5001-P | H-2Kb OVA peptide | 2022/04/28 | MBL |
TS-5008-P | H-2Db HPV16 E7 peptide | 2022/04/28 | MBL |
TS-M001-P | HLA-A*24:02 EBV LMP2 peptide | 2022/04/28 | MBL |
TS-M002-P | HLA-A*24:02 EBV BRLF1 peptide | 2022/04/28 | MBL |
TS-M005-P | HLA-A*24:02 EBV EBNA3B Peptide | 2022/04/28 | MBL |
TS-M007-P | HLA-A*24:02 HIV env gp160 peptide | 2022/04/28 | MBL |
TS-M008-P | H-2Kb SIY peptide | 2022/04/28 | MBL |
TS-M017-P | HLA-A*02:01 HTLV-1 Tax11-19 Peptide | 2022/04/28 | MBL |
TS-M026-P | HLA-A*02:01 MPT51 Peptide | 2022/04/28 | MBL |
TS-M027-P | HLA-A*02:01 HIV gag peptide | 2022/04/28 | MBL |
TS-M035-P | HLA-A*24:02 EBV LMP2 C8S peptide TYGPVFMSL | 2022/04/28 | MBL |
TS-M069-P | HLA-A*02:01 EBV LMP2 peptide FLYALALLL | 2022/04/28 | MBL |
TS-M140-P | HLA-A*02:01 WT137-45 peptide | 2022/04/28 | MBL |
TS-M501-P | H-2Kb β-galactosidase peptide | 2022/04/28 | MBL |
TS-M502-P | H-2Db Influenza NP Peptide | 2022/04/28 | MBL |
TS-M503-P | H-2Kd LLO peptide | 2022/04/28 | MBL |
TS-M505-P | H-2Db human gp100 peptide | 2022/04/28 | MBL |
TS-M506-P | H-2Kd RSV Peptide | 2022/04/28 | MBL |
TS-M508-P | H-2Db Influenza NP Peptide | 2022/04/28 | MBL |
TS-M509-P | H-2Kb SeV Peptide | 2022/04/28 | MBL |
TS-M510-P | H-2Ld MCMV IE1 Peptide | 2022/04/28 | MBL |
TS-M512-P | H-2Db LCMV gp33 (C9M) Peptide | 2022/04/28 | MBL |
TS-M513-P | H-2Db LCMV NP396 peptide | 2022/04/28 | MBL |
TS-M514-P | H-2Ld LCMV NP118 Peptide | 2022/04/28 | MBL |
TS-M515-P | H-2Kd malaria Pb9 Peptide | 2022/04/28 | MBL |
TS-M516-P | H-2Dd HIV P18-I10 Peptide | 2022/04/28 | MBL |
TS-M517-P | H-2Dd BCG MPT51 Peptide | 2022/04/28 | MBL |
TS-M518-P | H-2Db CEA peptide | 2022/04/28 | MBL |
1
2